MERIT MEDICAL SYSTEMS INC
Surgical & Medical Instruments & Apparatus- 売上
- $1.5bn
- 時価総額
- $4.7bn
株価 $78.29 · 100株 7,829円
心臓病学や放射線学など幅広い医療分野で診断・治療用医療機器を製造販売し顧客のニーズに応じた製品やソリューションを提供
| 期 | 23/12 | 24/12 | 25/12 |
|---|---|---|---|
| 売上 | $1.3bn | $1.4bn | $1.5bn |
| 成長率 | — | 7.9% | 11.8% |
| 総利益 | $584m | $643m | $738m |
| 総利益率 | 46.4% | 47.4% | 48.7% |
| 販管費 | $374m | $400m | $455m |
| 販管費率 | 29.7% | 29.5% | 30.0% |
| 営利 | $124m | $156m | $185m |
| 営利率 | 9.9% | 11.5% | 12.2% |
| 純利益 | $94m | $120m | $128m |
| PBR | 3.9 | 3.4 | 2.9 |
| PSR | 3.7 | 3.4 | 3.1 |
| PGPR | 8.0 | 7.2 | 6.3 |
| PER | 49 | 39 | 36 |
| ネットキャッシュ | ▲$247m | ▲$364m | ▲$299m |
| EV/EBITDA | 22.9 | 19.4 | 16.1 |
| Rule of 40 | — | 19% | 24% |
| セールス効率 | — | 228% | 171% |
※Rule of 40は売上成長率+営業利益率、セールス効率は売上総利益増加÷販管費増加(販管費増のときのみ)
